Developed by Novocure, the portable Optune Pax system uses tumor treating fields aimed directly at the site of the cancer to disrupt cell reproduction. A Phase 3 clinical trial shows it improves survival by two months on average versus chemotherapy alone.
Developed by Novocure, the portable Optune Pax system uses tumor treating fields aimed directly at the site of the cancer to disrupt cell reproduction. A Phase 3 clinical trial shows it improves survival by two months on average versus chemotherapy alone.